IZILOX 400 mg/250 ml, solution for infusion 5 bottles of 250 ml
Active ingredients: Moxifloxacin hydrochloride, Moxifloxacin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion5 bottles of 250 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IZILOX 400 mg/250 ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre de 250 ml
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Oct 2010
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62419261CIP75769308CIP133400957693084Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MOXIFLOXACINEsolution | 400 mg · 250 ml de solution pour perfusion | FT |
| CHLORHYDRATE DE MOXIFLOXACINEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.